Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.56 and traded as low as $0.51. Elite Pharmaceuticals shares last traded at $0.56, with a volume of 1,988,049 shares traded.
Elite Pharmaceuticals Stock Down 0.3 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 3.52 and a quick ratio of 2.42. The firm has a market capitalization of $596.42 million, a P/E ratio of -55.83 and a beta of 0.25. The firm's fifty day moving average price is $0.56 and its 200-day moving average price is $0.37.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Stories
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
